A sulfur-resistant CuS-modified active coke for mercury removal from municipal solid waste incineration flue gas.

Adsorption is a typical method for air pollutant removal from flue gas. A CuS-modified active coke (CuS/AC) sorbent was developed to improve the elemental mercury removal efficiency from municipal solid waste incineration (MSWI) flue gas. The influences of the loading amount of CuS, reaction temperature, and flue gas components including O2, SO2, H2O, and HCl on Hg0 removal efficiency were investigated, respectively. The results showed that the mercury adsorption capacity of CuS/AC(20%) sorbent was about 7.17 mg/g with 50% breakthrough threshold, which is much higher than that of virgin active coke. The analysis of XPS indicated that HgS was the main species of mercury on spent CuS/AC, which implied that adsorption and oxidation were both included in Hg0 removal. S22- played a vital role in the oxidation of physically adsorbed Hg0. Meanwhile, the common components of MSWI flue gas exhibited no significant inhibition effect on Hg0 removal by CuS/AC sorbent. CuS/AC sorbent is a promising sorbent for the mercury removal from MSWI flue gas.

The Role of Heat Shock Protein 90B1 in Patients with Polycystic Ovary Syndrome.

Polycystic ovary syndrome (PCOS) is a heterogenetic disorder in women that is characterized by arrested follicular growth and anovulatory infertility. The altered protein expression levels in the ovarian tissues reflect the molecular defects in folliculogenesis. To identify aberrant protein expression in PCOS, we analyzed protein expression profiles in the ovarian tissues of patients with PCOS. We identified a total of 18 protein spots that were differentially expressed in PCOS compared with healthy ovarian samples. A total of 13 proteins were upregulated and 5 proteins were downregulated. The expression levels of heat shock protein 90B1 (HSP90B1) and calcium signaling activator calmodulin 1 (CALM1) were increased by at least two-fold. The expression levels of HSP90B1 and CALM1 were positively associated with ovarian cell survival and negatively associated with caspase-3 activation and apoptosis. Knock-down of HSP90B1 with siRNA attenuated ovarian cell survival and increased apoptosis. In contrast, ovarian cell survival was improved and cell apoptosis was decreased in cells over-expressing HSP90B1. These results demonstrated the pivotal role of HSP90B1 in the proliferation and survival of ovarian cells, suggesting a critical role for HSP90B1 in the pathogenesis of PCOS. We also observed a downregulation of anti-inflammatory activity-related annexin A6 (ANXA6) and tropomyosin 2 (TPM2) compared with the normal controls, which could affect cell division and folliculogenesis in PCOS. This is the first study to identify novel altered gene expression in the ovarian tissues of patients with PCOS. These findings may have significant implications for future diagnostic and treatment strategies for PCOS using molecular interventions.